Page 79 - Drug Class Review
P. 79
Drug Effectiveness Review Project
Alzheimer Drugs Authors: Birks et al. 37 Year: 2004 Country: Multinational NHS R&D Executive UK Study design: Meta-analysis Number of patients: 8 trials involving 3,450 participants To determine the clinical efficacy and safety of RIV for patients with dementia of Alzheimer’s type A total of 8 studies: Agid et al., 1998; Anand et al. B104, 1996; Anand et al. B105, 1996; Rösler et al., 1999; ADENA Programme B304 (published and unpublished data), 1998; ADENA Programme B351 (published and unpublished data), 1998; Corey-Bloom et al., 1998; Tai, 2000; Tai et al., 2000 Trials completed
Final Report Update 1 Efficacy/Effectiveness STUDY: FUNDING: DESIGN: AIMS OF REVIEW: STUDIES INCLUDED IN META-ANALYSIS TIME PERIOD COVERED: CHARACTERISTICS OF INCLUDED STUDIES: CHARACTERISTICS OF INCLUDED POPULATIONS: Alzheimer's Drugs
